Alk-Abello AS (AKBLF)
24.60
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Alk-Abello EPS Diluted (Quarterly): 0.1299 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1299 |
| March 31, 2024 | 0.1602 |
| December 31, 2023 | 0.0866 |
| September 30, 2023 | 0.073 |
| June 30, 2023 | 0.0438 |
| March 31, 2023 | 0.1009 |
| December 31, 2022 | 0.0426 |
| September 30, 2022 | 0.0271 |
| June 30, 2022 | 0.0286 |
| March 31, 2022 | 0.1056 |
| December 31, 2021 | 0.0523 |
| September 30, 2021 | 0.027 |
| June 30, 2021 | -0.0162 |
| March 31, 2021 | 0.094 |
| December 31, 2020 | -0.0227 |
| September 30, 2020 | -0.0141 |
| June 30, 2020 | -0.0066 |
| March 31, 2020 | 0.0576 |
| December 31, 2019 | -0.0088 |
| September 30, 2019 | -0.0209 |
| June 30, 2019 | -0.0466 |
| March 31, 2019 | 0.0312 |
| December 31, 2018 | -0.1035 |
| September 30, 2018 | -0.0187 |
| June 30, 2018 | -0.0128 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.0181 |
| December 31, 2017 | -0.1169 |
| September 30, 2017 | -0.019 |
| June 30, 2017 | -0.0008 |
| March 31, 2017 | 0.0015 |
| December 31, 2016 | 0.0254 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.0531 |
| March 31, 2016 | 0.0887 |
| December 31, 2015 | 0.1023 |
| September 30, 2015 | 0.0447 |
| June 30, 2015 | 0.037 |
| March 31, 2015 | 0.0685 |
| December 31, 2014 | 0.0138 |
| September 30, 2014 | 0.0234 |
| June 30, 2014 | 0.0288 |
| March 31, 2014 | 0.10 |
| December 31, 2013 | 0.0373 |
| September 30, 2013 | 0.0082 |
| June 30, 2013 | -0.0272 |
| March 31, 2013 | 0.0381 |
| December 31, 2012 | -0.013 |
| September 30, 2012 | 0.0481 |
| June 30, 2012 | 0.1126 |
| March 31, 2012 | 0.036 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.0227
Minimum
Dec 2020
0.1602
Maximum
Mar 2024
0.047
Average
0.0432
Median
EPS Diluted (Quarterly) Benchmarks
| Genmab AS | 0.3132 |
| Ascendis Pharma AS | -2.057 |
| Galecto Inc | -5.00 |
| Evaxion Biotech AS | -1.20 |
| IO Biotech Inc | -0.31 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 29.01M |
| Revenue (Quarterly) | 198.33M |
| Total Expenses (Quarterly) | 160.22M |
| Enterprise Value | 5.412B |
| Gross Profit Margin (Quarterly) | 63.10% |
| Profit Margin (Quarterly) | 14.63% |
| Earnings Yield | 1.83% |
| Operating Earnings Yield | 2.40% |
| Normalized Earnings Yield | 1.828 |